• Login
    View Item 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Self Harm and Suicide
    • View Item
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Self Harm and Suicide
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Ketamine for suicidal ideation: New trial challenges current thinking about ketamine

    Thumbnail
    Date
    2022-02
    Author
    De Giorgi, Riccardo
    Metadata
    Show full item record
    Citation
    Riccardo De Giorgi. Ketamine for suicidal ideation: New trial challenges current thinking about ketamine. BMJ 2022;376:o74
    Abstract
    Will ketamine be given to eligible patients with suicidal ideation any time soon? This is hard to say, given the plausible concern that the widespread use of ketamine might trigger a new opioid style crisis.10 Whether ketamine reduces suicidal ideation in some people is a matter of evidence —which this trial by Abbar and colleagues provides. But whether the emergency use of ketamine for suicidal crises will be recommended in practice depends on many other factors, including the values and preferences of patients, clinicians, researchers, and policymakers.
    Description
    Open Access
    URI
    https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1052
    Published online at:
    https://doi.org/10.1136/bmj.o74
    Collections
    • Self Harm and Suicide [56]

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc
     

     

    Browse

    All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

    My Account

    Login

    Researcher Profiles

    Researchers

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc